fashion -WSS

fashion

author：explore 2025-10-02 01:12:34 - browse：7

SAN DIEGO — One of the toughest subtypes of acute leukemia involves a genetic alteration in the KMT2A gene. Many cancers with this genetic alteration end up relapsing or don’t respond to treatment, but new data presented at the annual American Society of Hematology meeting offer hope of a new targeted therapy for these patients.

The study, called the Phase 2 Augment-101 trial, tested Syndax’s revumenib in patients with relapsed or refractory leukemia with these KMT2A genetic rearrangements. Overall, about 63% of the patients responded to the treatment, with many able to receive a potentially curative stem cell transplant later on, which is often the ultimate goal for patients with relapsed or refractory patients, said Ibrahim Aldoss, a hematologist-oncologist at City of Hope and the study’s presenter, in an interview.

“KMT2A-rearranged diseases represent 10% of all leukemia. They can be exceptionally hard to treat,” Aldoss said. “The median overall survival remains low with current available treatment. Right now there’s no targeted therapy for KMT2A-rearranged disease. We’re really excited about revumenib as it targets the mutation, and we’re seeing encouraging outcomes.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Doctors have an ethical obligation to be advocates

WSS

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Search warrant issued in 1996 disappearance of Kristin Smart

PrEP can help anyone prevent HIV. Why do so few people take it?

Transgender women dream of pregnancy via uterus transplants

A bus careens into a gulch in southern Mexico, leaving 27 people dead

hotspot

fashion

focus

Psychedelics group wrestles with new pharma identity

Malaysia cuts short music fest after British band slams anti

Novavax promises a turnaround & Lilly roils the obesity market

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

ChatGPT in medicine: STAT answers readers' burning questions

PrEP can help anyone prevent HIV. Why do so few people take it?

Medical records are filled with copy

City of Memphis, police chief oppose effort to delay lawsuit in Tyre Nichols case

Anesthesiologist group: stop taking Ozempic before surgery

Man with guns arrested near Obama home 'attempted to evade' Secret Service: Prosecutors

knowledge

5 shark bites reported on Long Island as officials deploy surveillance drones

A bus careens into a gulch in southern Mexico, leaving 27 people dead

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Clinic falsely told dozens they had Alzheimer's, suits say

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

focus

hotspot

focus

knowledge